This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Post Holdings (POST) Q3 Earnings Miss Estimates, Sales Up Y/Y
by Zacks Equity Research
Post Holdings (POST) third-quarter performance reflects gains from acquisitions, recovery in foodservice channel as well as strong brand performance across certain categories.
B&G Foods (BGS) Q2 Earnings Miss Estimates, Sales Down Y/Y
by Zacks Equity Research
B&G Foods (BGS) second-quarter fiscal 2021 results reflect lower earnings and sales on unfavorable year-over-year comparisons. Also, input cost inflation affected quarterly results.
5 Top-Performing Liquid Stocks to Snap Up for Higher Returns
by Zacks Equity Research
Here are five top-ranked liquid stocks, Magnolia Oil & Gas (MGY), Medifast (MED), Textron (TXT), ConocoPhillips (COP) and Steven Madden (SHOO), which investors can consider for attractive returns.
TreeHouse Foods (THS) Q2 Earnings Meet Estimates, Stock Down
by Zacks Equity Research
TreeHouse Foods' (THS) second-quarter 2021 results reflect lower earnings and sales. Management curtails 2021 guidance.
Nu Skin (NUS) Q2 Earnings Beat Estimates, Sales Grow Y/Y
by Zacks Equity Research
Nu Skin's (NUS) second-quarter 2021 earnings and revenues increase year over year on growth in sales leaders. Also, management raises 2021 earnings view.
Medifast (MED) Surpasses Q2 Earnings & Revenue Estimates
by Zacks Equity Research
Strength in independent OPTAVIA Coaches along with gross margin expansion and lower SG&A expense rate aids Medifast (MED) in Q2.
Kellogg's (K) Q2 Earnings Top Estimates, Organic Sales View Up
by Zacks Equity Research
Kellogg's (K) second-quarter 2021 results reflect tough comparisons with the year-ago period, though away-from-home channel recovery and emerging market strength were upsides.
Medifast (MED) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Medifast (MED) delivered earnings and revenue surprises of 20.00% and 7.70%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Kraft Heinz (KHC) Q2 Earnings Beat Estimates, Sales Down Y/Y
by Zacks Equity Research
Kraft Heinz's (KHC) second-quarter 2021 sales and earnings decline year over year on softness across United States business.
Here's How Post Holdings (POST) is Placed Before Q3 Earnings
by Zacks Equity Research
Post Holdings' (POST) third-quarter fiscal 2021 results are likely to reflect gains from its prudent buyouts as well as strength across the BellRing Brands segment.
Is Medifast (MED) a Solid Growth Stock? 3 Reasons to Think " Yes "
by Zacks Equity Research
Medifast (MED) possesses solid growth attributes, which could help it handily outperform the market.
Everything Worth Noting Ahead of Kellogg's (K) Q2 Earnings
by Zacks Equity Research
Kellogg's (K) second-quarter 2021 results are likely to reflect escalated costs and moderation in at-home consumption-related demand. That said, the company's brand strength has been a driver.
B&G Foods (BGS) Queued for Q2 Earnings: Key Things to Note
by Zacks Equity Research
B&G Foods' (BGS) second-quarter 2021 results are likely to reflect escalated input costs for ingredients, packaging and transportation, though rising online sales have been aiding.
Nu Skin (NUS) Queued for Q2 Earnings: Key Things to Note
by Zacks Equity Research
Nu Skin's (NUS) second-quarter 2021 performance is likely to reflect gains from the company's efforts to strengthen sales leader and expand customer. Also, online strength has been a driver.
Church & Dwight (CHD) Cuts View Despite Q2 Earnings & Sales Beat
by Zacks Equity Research
Church & Dwight's (CHD) second-quarter 2021 results benefit from strong product demand. Management lowers view due to supply-chain woes and cost inflation.
Medifast (MED) Queued for Q2 Earnings: Key Things to Note
by Zacks Equity Research
Medifast's (MED) second-quarter 2021 results are likely to reflect continued strength in OPTAVIA lifestyle solution and coaching support system.
Kraft Heinz (KHC) Gears Up to Post Q2 Earnings: What in Store?
by Zacks Equity Research
Kraft Heinz's (KHC) second-quarter 2021 performance is likely to reflect adverse impacts from escalated cost inflation. Nevertheless, focus on operating model bodes well.
Service Corporation's (SCI) Q2 Earnings Top Estimates, View Raised
by Zacks Equity Research
Service Corporation's (SCI) second-quarter 2021 results reflect solid earnings and sales, on strength in comparable preneed cemetery sales production and comparable preneed funeral sales production.
Hershey's (HSY) Q2 Earnings Surpass Estimates, Sales Up Y/Y
by Zacks Equity Research
Hershey's (HSY) second-quarter 2021 results reflect higher sales and earnings on strength across North America as well as International and Other unit. Management raises 2021 net sales view.
Pilgrim's Pride (PPC) Q2 Earnings Top Estimates, Sales Up Y/Y
by Zacks Equity Research
Pilgrim's Pride's (PPC) second-quarter 2021 results reflect higher sales and earnings on strength across Mexico, the U.K. and Europe as well as the U.S. operations.
Medifast (MED) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Medifast (MED) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Mondelez (MDLZ) Q2 Earnings Match Estimates, Revenues Beat
by Vrishali Bagree
Mondelez International's (MDLZ) second-quarter 2021 results reflect a rise in earnings and sales. A solid first-half performance led to a raised organic revenue growth view, though high costs are a concern.
Clorox (CLX) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Elevated manufacturing and logistics costs might have hurt Clorox's (CLX) bottom line in fourth-quarter fiscal 2021. Nonetheless, its IGNITE strategy and cost-saving initiatives are encouraging.
Freshpet (FRPT) to Post Q2 Earnings: What Awaits the Stock?
by Zacks Equity Research
Freshpet's (FRPT) second-quarter performance is likely to have gained from strong consumption trends. However, rising freight and beef costs are a concern.
Have Faith in DuPont Analysis: Buy 5 Top-Ranked Stocks
by Sanghamitra Saha
DuPont technique helps investors to analyze basic ROE at an advanced level. Bet on these five stocks.